Field Medical has generated another $35 million in venture capital funding for its cardiac pulsed field ablation system to support the launch of a pivotal trial. | The series B financing comes quickly ...

Clinicians can simulate therapy responses using digital twins to predict treatment outcomes and adjust care plans in a controlled virtual environment.

When it comes to cutting-edge health technology, Jecizer Biosciences is quickly becoming the name you’ve probably haven’t ...

A n estimated 50 million people live with the irritating symptoms of dry eye, including redness, blurry vision, and a ...

Field Medical announced today that it has closed a Series B funding round worth proceeds totaling $35 million.

BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia ...